Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
about
Pharmaceutical policies: effects of cap and co-payment on rational use of medicinesThe effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysisUniversal prescription drug coverage in Canada: Long-promised yet undeliveredAssociation between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic reviewAssessing barriers to health insurance and threats to equity in comparative perspective: the Health Insurance Access Database.Costs and benefits of free medications after myocardial infarction.Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors: challenges in comparative effectiveness using Medicare data.Estimates of commercial population at high risk for cardiovascular events: impact of aggressive cholesterol reductionUnderstanding patient perspectives on communication about the cost of cancer care: a review of the literature.Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarctionBenefits of statin therapy and compliance in high risk cardiovascular patients.Predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries.Nonlinear pricing in drug benefits and medication use: the case of statin compliance in Medicare Part D.Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement.Reasons for discontinuation of lipid-lowering medications in patients with chronic kidney disease.Physician and patient influences on provider performance: β-blockers in postmyocardial infarction management in the MI-Plus study.Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β₂ -agonists in obstructive lung diseases: a population-based, observational studyThe impact of regional co-payment and national reimbursement criteria on statins use in Italy: an interrupted time-series analysis.National Background is Associated with Disparities in Initiation and Persistence to Statin Treatment in Subjects with Diabetes in Denmark.How patient cost-sharing trends affect adherence and outcomes: a literature review.Does medication adherence following a copayment increase differ by disease burden?Diagnosing medication non-adherence in a patient with myocardial infarction.Association between sitagliptin adherence and self-monitoring of blood glucose.Predictors of nonadherence to statins: a systematic review and meta-analysis.The effect of transitioning to medicare part d drug coverage in seniors dually eligible for medicare and medicaid.Association of Medicare Part D medication out-of-pocket costs with utilization of statin medicationsRationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial.The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefitsOut-of-pocket prices of opioid analgesics in the United States, 1999-2004Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans.Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997- 2006.Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006.Medicines Compliance and Reimbursement Level in Portugal.Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study.The effects of catastrophic drug plan deductibles on older women's use of cardiovascular medicines: a retrospective cohort study.Dynamics of long-term statin therapy.Patient co-payment and adherence to statins: a review and case studies.Role of depressive symptoms and self-efficacy of medication adherence in Korean patients after successful percutaneous coronary intervention.Medication Nonadherence: The Role of Cost, Community, and Individual Factors.The cost of pharmaceutical innovation to patients.
P2860
Q24188009-2D248014-049F-4D00-955B-74D8E67B1B34Q26829072-48991B23-0F8C-459D-BB53-66FFD191E988Q28069734-84018944-BDA6-45B0-B2C3-E5B4C9B87BE2Q28541457-BDFB0F59-E86E-4358-8882-2C23E6109BDCQ31060705-77706B93-E6EC-448F-A074-D0995873A167Q33585275-C228CA60-33CD-4F36-A8D2-E5A665F665A6Q33858023-279E6FA8-669A-41D4-BCAE-C2FB7B3A7593Q33931921-08586FB2-D556-4109-AB65-FE66AB632E8AQ33978909-2D65121D-91B0-4902-9270-E7EAB0002DCBQ34001855-EE2B3826-3710-43A0-A9F9-22AC8EAD0D67Q34187551-6C2769F1-1941-48EB-96C7-0D1F15440297Q34246573-9C2852D0-5861-40E6-9A45-BD441A70E5A1Q34509195-1A16A400-F6EC-43AF-8A09-0656E905B289Q34772182-FCE86ED9-F342-4379-8E5A-2C7A414F6F05Q34985796-2838BE9C-380F-4AD9-B13D-B99BA5884E39Q34997242-25494F85-4765-49E0-A76B-A28EE6C55B7AQ35022943-7468019B-F03F-4037-90D0-BC70BA2948CEQ35083824-753C353E-9EB8-4E47-9835-7A73A419616CQ35155256-E9C0637B-02BF-4CD9-8FCB-9B26201571C3Q35752951-E5370E9A-0AA5-4DF8-A4F9-8E6EE76CD116Q36085521-A3CB26B1-2E7E-4EF1-B074-C32B474BB94EQ36137866-78A90014-6FE1-4BB3-89A2-BA313ED24912Q36228968-A6E514DC-C860-4DB8-871E-5A0D25464BF8Q36809178-686F1E2C-453E-4E26-81A3-228C004386C1Q37023504-6BD91994-F53F-4D08-BF76-F10601D77292Q37050954-65283876-B50D-43FA-9B45-0CED90FB62D4Q37196480-EA119AC1-6806-4EF8-A16A-397A71BC169FQ37196554-69068425-47C4-4DB3-ADC4-CCE3675CBFA2Q37265102-C2683273-6E20-4550-9F3B-63C688FF3A6DQ37365655-97E7CABC-F277-43B0-81E5-C9163576211CQ37475711-87526F86-C891-4C4D-B6BB-05E6000EDB1BQ37556063-CEAEBF32-0D27-4C08-AE83-F9A97FB55076Q37606776-78BFDBCF-BAB5-49F9-9263-BA5BC8C09CA5Q37693536-1928E4C8-AD77-472C-9B86-3A6F7986AA8DQ37735873-E28A8ECA-0212-429C-B70D-A49F5756BB43Q37853479-051AAE5E-F7C3-432B-9B56-BEA4CF47D354Q38154826-DE135842-06CD-419F-AEED-FE2486435E4BQ39334425-14CDCDFD-E1A9-4D89-87AF-33A46BDE0737Q39455827-2AAA305B-BCA3-4AC8-88EA-87917FAAE450Q40159176-9B57A037-B2C8-4822-BBE1-1CB18B72B0CE
P2860
Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Adherence to statin therapy un ...... tion-based natural experiment.
@en
Adherence to statin therapy un ...... tion-based natural experiment.
@nl
type
label
Adherence to statin therapy un ...... tion-based natural experiment.
@en
Adherence to statin therapy un ...... tion-based natural experiment.
@nl
prefLabel
Adherence to statin therapy un ...... tion-based natural experiment.
@en
Adherence to statin therapy un ...... tion-based natural experiment.
@nl
P2093
P1433
P1476
Adherence to statin therapy un ...... tion-based natural experiment.
@en
P2093
Amanda R Patrick
Malcolm Maclure
Robert J Glynn
Sebastian Schneeweiss
P304
P356
10.1161/CIRCULATIONAHA.106.665992
P407
P577
2007-04-09T00:00:00Z